William E. Kennard - 14 Dec 2022 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Anthony Lukaszewski, Authorized Signer
Issuer symbol
MET
Transactions as of
14 Dec 2022
Net transactions value
+$16,753
Form type
4
Filing time
16 Dec 2022, 15:25:10 UTC
Previous filing
05 Dec 2022
Next filing
05 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $16,753 +230 +0.69% $72.84 33,783 14 Dec 2022 Direct F1
holding MET Common Stock 10 14 Dec 2022 By the MetLife Policyholder Trust F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife Inc. common stock that have become payable, but receipt of which the director has deferred.
F2 Shares held in trust under the MetLife Policyholder Trust established to hold shares of Common Stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.